CS
ORIAW

Clear Street’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Clear Street’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,690
Closed -$1K – 1394
2022
Q4 		$1K Hold
5,690
– – ﹤0.01% 1006
2022
Q3 		$1K Hold
5,690
– – ﹤0.01% 1120
2022
Q2 		$1K Buy
+5,690
New +$1.84K ﹤0.01% 982

Other funds holding ORIAW

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Clear Street's ORIAW Position: Q1 2023 in Review

Clear Street sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q1 2023, closing a stake of 5,690 shares — an estimated $1K sold.

Clear Street first reported a position in ORIAW in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q4 2022. 25 funds tracked by Wall St. Rank hold ORIAW as of Q1 2023.

  • Clear Street reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Clear Street sold 5,690 Orion Biotech Opportunities Corp. Warrant shares in Q1 2023, an estimated $1K.
  • Clear Street first reported a position in Orion Biotech Opportunities Corp. Warrant in Q2 2022 and held it in 3 quarters.
  • Clear Street's Orion Biotech Opportunities Corp. Warrant position peaked at $1K in Q4 2022.
  • 25 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.